September 5, 2018 – Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough […] A company whose prescription opioid marketing practices are being blamed for sparking the addiction and overdose crisis says it’s helping […] Many patients want more information on the medicines they’re prescribed and greater say in the brands they use, the first […] KENILWORTH, N.J.–(BUSINESS WIRE) August 30, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today […] The Trump administration on Thursday released a safety training video for emergency responders that aims to dispel myths about the […] According to the manufacturer, GlaxoSmithKline, the demand for Shingrix has been “unprecedented,” and has resulted in a country-wide shortage. Glaxo […] DUBLIN, Aug. 1, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) today announced positive four-week results from a […] US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring […] In February earlier this year, Larry was diagnosed with a long-term breathing problem very similar to chronic obstructive pulmonary disease […] GEORGE TOWN, Cayman Islands–(BUSINESS WIRE)August 09, 2018 –Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”) a wholly owned subsidiary of Highland Therapeutics […]Medications
Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata
Major opioid maker to pay for overdose-antidote development
New study finds patients want more information about their medicine
FDA Approves Delstrigo
Death from touching fentanyl? A myth, says Trump administration training video
Shingrix Shortage May Last Until 2019. Here’s How to Get it Now
Theravance Biopharma Reports Positive Top-Line Four-Week Data from Phase 2 Trial of TD-9855 for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
US approves first generic competitor to Mylan’s EpiPen
Larry the Chiweenie Saves 65% on His COPD Pet Medicine
FDA Approves Jornay PM
Copyright © 2025